Job/Unit: I20549
/KAP1
Date: 13-08-12 11:39:00
Pages: 11
Supramolecular Hybrid Bidentate Ligands
β-dex 225) isothermal at 140 °C for 14.0 min, 50 °Cmin–1 to
220 °C; tR(S) = 15.22 min, tR(R) = 15.36 min, tR(15b) = 12.70 min.
[9]
For detailed overviews, see these reviews: a) P. W. N. M.
van Leeuwen, P. C. Kamer, C. Claver, O. Pamies, M. Dieguez,
Chem. Rev. 2011, 111, 2077–2118; b) J. Wassenaar, J. N. H.
Reek, Org. Biomol. Chem. 2011, 9, 1704–1713.
a) A. Lightfoot, P. Schnider, A. Pfaltz, Angew. Chem. 1998,
110, 3047; Angew. Chem. Int. Ed. 1998, 37, 2897–2899; b) S. J.
Roseblade, A. Pfaltz, Acc. Chem. Res. 2007, 40, 1402–1411.
G. Helmchen, S. Kudis, P. Sennhenn, H. Steinhagen, Pure Appl.
Chem. 1997, 69, 513–518.
a) K. Kallstrom, C. Hedberg, P. Brandt, A. Bayer, P. G. An-
dersson, J. Am. Chem. Soc. 2004, 126, 14308–14309; b) C. Hed-
berg, K. Källström, P. Brandt, L. K. Hansen, P. G. Andersson,
J. Am. Chem. Soc. 2006, 128, 2995–3001.
2-Methyl (Z)-Acetamido-3-phenylacrylate (15c): The conversion
and enantiomeric excess were calculated by chiral GC analysis
(Chirasil DEX-CB) isothermal at 90 °C, 5 °Cmin–1 to 220 °C;
tR(R) = 15.35 min, tR(S) = 15.49 min, tR(15c) = 16.50 min.
[10]
[11]
[12]
Methyl 2-Hydroxymethylacrylate (16): The conversion and enantio-
meric excess were calculated by chiral HPLC analysis (Chiralcel
AD-H) flow rate: 1.0 mLmin–1, eluent: heptane/2-propanol (90:10),
detection at 210 nm; tR(R) = 7.51 min, tR(S) = 9.51 min, tR(16) =
17.52 min.
[13]
a) D. A. Evans, K. R. Campos, J. S. Tedrow, F. E. Michael,
M. R. Gagne, J. Am. Chem. Soc. 2000, 122, 7905–7920; b)
D. A. Evans, F. E. Michael, J. S. Tedrow, K. R. Campos, J. Am.
Chem. Soc. 2003, 125, 3534–3543.
[Rh(1a)(8)2(nbd)]BF4: [Rh(nbd)2]BF4 (7.5 mg, 20.0 μmol), ligand 1a
(15.3 mg, 20.0 μmol) and template 8 (24.2 mg, 40.0 μmol) were dis-
solved in CH2Cl2 (0.6 mL) and stirred at room temperature for
3 h to allow complex formation. 31P NMR (CD2Cl2, 202.3 MHz,
298 K): δ = 131.7 (dd, JP,Rh = 260.1 Hz, JP,P = 66.0 Hz), 19.9 (dd,
JP,Rh = 148.7 Hz, JP,P = 66.0 Hz) ppm.
[14]
[15]
[16]
a) M. Rubio, A. Suárez, E. Álvarez, A. Pizzano, Chem. Com-
mun. 2005, 628–630; b) M. Rubio, S. Vargas, A. Suárez, E.
Álvarez, A. Pizzano, Chem. Eur. J. 2007, 13, 1821–1833.
a) G. Franciò, F. Faraone, F. Leitner, Angew. Chem. 2000, 112,
1486; Angew. Chem. Int. Ed. 2000, 39, 1428; b) S. Burk, G.
Franciò, W. Leitner, Chem. Commun. 2005, 3460–3462.
a) J. Wassenaar, J. N. H. Reek, Dalton Trans. 2007, 3750–3753;
b) J. Wassenaar, M. Kuil, J. N. H. Reek, Adv. Synth. Catal.
2008, 350, 1610–1614; c) J. Wassenaar, J. N. H. Reek, J. Org.
Chem. 2009, 74, 8403–8406.
[Rh(1b)(8)2(nbd)]BF4: [Rh(nbd)2]BF4 (7.5 mg, 20.0 μmol), ligand 1b
(15.3 mg, 20.0 μmol) and template 8 (24.2 mg, 40.0 μmol) were dis-
solved in CH2Cl2 (0.6 mL) and stirred at room temperature for
3 h to allow complex formation. 31P NMR (CD2Cl2, 202.3 MHz,
298 K): δ = 131.7 (dd, JP,Rh = 268.9 Hz, JP,P = 66.5 Hz), 17.3 (dd,
JP,Rh = 146.8 Hz, JP,P = 66.5 Hz) ppm.
[17]
[18]
W. Zhang, X. Zhang, Angew. Chem. 2006, 118, 5641; Angew.
[Rh(1a)(nbd)]BF4: [Rh(nbd)2]BF4 (7.5 mg, 20.0 μmol) and ligand 1a
(15.3 mg, 20.0 μmol) were dissolved in CH2Cl2 (0.6 mL) and stirred
at room temperature for 3 h to allow complex formation. 31P NMR
(CD2Cl2, 202.3 MHz, 298 K): δ = 142.0 (br. s), 35.0 (br. s) ppm.
Chem. Int. Ed. 2006, 45, 5515–5518.
a) D.-Y. Wang, X.-P. Hu, J.-D. Huang, J. Deng, S.-B. Yu, Z.-
C. Duan, X.-F. Xu, Z. Zheng, Angew. Chem. 2007, 119, 7956;
Angew. Chem. Int. Ed. 2007, 46, 7810–7813; b) S.-B. Yu, J.-D.
Huang, D.-Y. Wang, X.-P. Hu, J. Deng, Z.-C. Duan, Z. Zheng,
Tetrahedron: Asymmetry 2008, 19, 1862–1866.
K. A. Vallianatou, I. D. Kostas, J. Holz, A. Börner, Tetrahedron
Lett. 2006, 47, 7947–7950.
[Rh(1b)(nbd)]BF4: [Rh(nbd)2]BF4 (7.5 mg, 20.0 μmol) and ligand 1b
(15.3 mg, 20.0 μmol) were dissolved in CH2Cl2 (0.6 mL) and stirred
at room temperature for 3 h to allow complex formation. 31P NMR
(CD2Cl2, 202.3 MHz, 298 K): δ = 141.5 (br. s), 36.6 (br. s) ppm.
[19]
[20]
a) B. Breit, Angew. Chem. 2005, 117, 6976; Angew. Chem. Int.
Ed. 2005, 44, 6816–6825; b) M. J. Wilkinson, P. W. N. M.
van Leeuwen, J. N. H. Reek, Org. Biomol. Chem. 2005, 3, 2371–
2383; c) A. J. Sandee, J. N. H. Reek, Dalton Trans. 2006, 3385–
3391; d) G. Gasparini, M. Dal Molin, L. J. Prins, Eur. J. Org.
Chem. 2010, 2429–2440; e) S. Carboni, C. Gennari, L. Pignat-
aro, U. Piarulli, Dalton Trans. 2011, 40, 4355–4373; f) J. Meeu-
wissen, J. N. H. Reek, Nature Chem. 2010, 2, 615–621; g)
P. W. N. M. van Leeuwen, Supramolecular Catalysis, Wiley-
VCH, Weinheim, 2008; h) P. E. Goudriaan, P. W. N. M.
van Leeuwen, M. N. Birkholz, J. N. H. Reek, Eur. J. Inorg.
Chem. 2008, 2939–2958; i) R. Bellini, J. I. van der Vlugt,
J. N. H. Reek, Isr. J. Chem. 2012, DOI: 10.1002/ijch.201200002.
a) X.-B. Jiang, L. Lefort, P. E. Goudriaan, A. H. M. de Vries,
P. W. N. M. van Leeuwen, J. G. de Vries, J. N. H. Reek, Angew.
Chem. 2006, 118, 1245; Angew. Chem. Int. Ed. 2006, 45, 1223–
1227; b) S. A. Moteki, J. M. Takacs, Angew. Chem. 2008, 120,
908; Angew. Chem. Int. Ed. 2008, 47, 894–897.
a) M. Weis, C. Waloch, W. Seiche, B. Breit, J. Am. Chem. Soc.
2006, 128, 4188–4189; b) J. Wieland, B. Breit, Nature Chem.
2010, 2, 832–837; c) A. C. Laungani, B. Breit, Chem. Commun.
2008, 844–846; d) A. J. Sandee, A. M. van der Burg, J. N. H.
Reek, Chem. Commun. 2007, 864–866; e) J. Meeuwissen, M.
Kuil, A. M. van der Burg, A. J. Sandee, J. N. H. Reek, Chem.
Eur. J. 2009, 15, 10272–10279; f) F. W. Patureau, M. Kuil, A. J.
Sandee, J. N. H. Reek, Angew. Chem. 2008, 120, 3224; Angew.
Chem. Int. Ed. 2008, 47, 3180–3183; g) F. W. Patureau, S.
de Boer, M. Kuil, J. Meeuwissen, P.-A. R. Breuil, M. A. Siegler,
A. L. Spek, A. J. Sandee, B. de Bruin, J. N. H. Reek, J. Am.
Chem. Soc. 2009, 131, 6683–6685; h) J. Meeuwissen, R. Detz,
A. J. Sandee, B. de Bruin, M. A. Siegler, A. L. Spek, J. N. H.
Reek, Eur. J. Inorg. Chem. 2010, 2992–2997; i) J. Meeuwissen,
A. J. Sandee, B. de Bruin, M. A. Siegler, A. L. Spek, J. N. H.
Reek, Organometallics 2010, 29, 2413–2421; j) Y. Liu, Y. Yama-
[Rh(1c)(nbd)]BF4: [Rh(nbd)2]BF4 (7.5 mg, 20.0 μmol) and ligand 1c
(15.3 mg, 20.0 μmol) were dissolved in CH2Cl2 (0.6 mL) and stirred
at room temperature for 3 h to allow complex formation. 31P NMR
(CD2Cl2, 202.3 MHz, 298 K): δ = 134.8 (dd, JP,Rh = 266.2 Hz, JP,P
= 64.0 Hz), 18.0 (dd, JP,Rh = 150.2 Hz, JP,P = 64.0 Hz) ppm.
Acknowledgments
We thank InCatT B.V. for providing substrate 16. Vladica Bocokic
is kindly acknowledged for the synthesis of template 17. This work
was financially supported by the National Research School Combi-
nation Chemistry (NRSC-C).
[21]
[22]
[1] J. G. de Vries, C. J. Elsevier, The Handbook of Homogeneous
Hydrogenation, Wiley-VCH, Weinheim, 2007.
[2] a) W. Tang, X. Zhang, Chem. Rev. 2003, 103, 3029–3069; b) J.-
H. Xie, S.-F. Zhu, Q.-L. Zhou, Chem. Rev. 2011, 111, 1713–
1760.
[3] L. Horner, H. Siegel, H. Buthe, Angew. Chem. 1968, 80, 1034;
Angew. Chem. Int. Ed. Engl. 1968, 7, 942.
[4] W. S. Knowles, M. J. Sabacky, Chem. Commun. 1968, 1445.
[5] T.-P. Dang, H. B. Kagan, J. Am. Chem. Soc. 1971, 93, 481.
[6] W. S. Knowles, M. J. Sabacky, B. D. Vineyard, D. J. Weinkauff,
J. Am. Chem. Soc., 1975, 97, 2567.
[7] a) A. Miyashita, A. Yasuda, H. Takaya, K. Toriumi, T. Ito, T.
Souchi, R. Noyori, J. Am. Chem. Soc. 1980, 102, 7932–7934;
b) R. Noyori, Angew. Chem. 2002, 114, 2108; Angew. Chem.
Int. Ed. 2002, 41, 2008–2022.
[8] a) M. J. Burk, J. Am. Chem. Soc. 1991, 113, 8518–8519; b) M. J.
Burk, Acc. Chem. Res. 2000, 33, 363–372.
Eur. J. Inorg. Chem. 0000, 0–0
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjic.org
9